Dr. Thomas Fuchs on the use of AI in combating cancer

Paige Chief Scientist and Founder Dr. Thomas Fuchs was interviewed Fox News sharing how AI like Paige’s can truly revolutionize cancer care, from helping to reduce diagnostic errors by 70% to giving patients greater peace of mind. Watch the full interview

‘Clever AI tool can help pick up prostate cancer quickly’

Dr. Miriam Stoppard shared her support for the introduction of AI tools to support early prostate cancer detection with The Mirror. Acknowledging Oxford University, who have introduced the AI applications included in the Paige Prostate Suite to support patient diagnosis, she explained the value that AI-powered tools like Paige can bring to prostate cancer care. […]

Digital Pathology Use in Labs Growing, But Barriers to Adoption Remain

Digital pathology has accelerated greatly since the first approval of a digital slide scanner in 2017, especially throughout the COVID-19 pandemic and as pressures from a dwindling pathology workforce have continued to rise. However, there are still some barriers to adoption that have prevented labs from tapping into the many benefits of digital pathology. Paige […]

Paige Named Award Recipient of the PathLAKE Plus AI Project under HealthTrust Europe’s National Tender for Artificial Intelligence Solutions

Paige has been awarded the opportunity to provide, if chosen, artificial intelligence applications to leading NHS Trust labs through PathLAKE Plus, a consortium dedicated to driving AI innovation in pathology for the UK. Through the digitization of five major NHS laboratories and the formation of a computational pathology hub, PathLAKE aims to ensure that the […]

The future is now: AI and more effective cancer screening

AI offers a host of benefits for cancer care, especially as the market develops and adoption increases. As the first and only company to receive FDA approval for an AI in pathology, Paige has been blazing the trail forward, and our Chief Medical Officer Dr. David Klimstra spoke with PharmaPhorum on how we envision AI […]